secwatch.observer — SEC 8-K summary
======================================

Issuer:     Comera Life Sciences Holdings, Inc. (—)
CIK:        0001907685
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0000950170-24-008939
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 2.04, 8.01, 2.05, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Comera terminates all employees after Regeneron deal failure triggers default on $1.5M notes
--------------------------------------------------------------------------------

- Regeneron notified Jan 26 it won't negotiate license under research collaboration; triggers Event of Default on $1.5M 12% Senior Secured Convertible Notes.
- Board approved termination of all employees, including CEO Jeff Hackman, CFO Michael Campbell, CSO Robert Mahoney, effective Jan 31, 2024.
- CFO Campbell terminated then rehired as consultant CEO/CFO at $2,400/day; Hackman and Wexler resigned from board.
- Purchasers of December 2023 notes withdrew prior exercise of Share Purchase Option to acquire remaining common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1907685/000095017024008939/0000950170-24-008939-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1907685/000095017024008939/cmra-20240126.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-008939

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer